TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23610100

Group type: EXPERIMENTAL
Intervention: Colestilan 9 g/day
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Colestilan 12/15 g/day (pooled)
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Colestilan 3 g/day
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Colestilan 6 g/day
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Colestilan (various doses)
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: Colestilan
Number of subjects: 642

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 642
Study: 21886361

Group type: EXPERIMENTAL
Intervention: Sleep deprivation (maximum of 2 hours of sleep)
Number of subjects: 55
Study: 19128767

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking-placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking-24% sucrose
Number of subjects: 150

Group type: COMPARATOR
Intervention: No specific analgesic intervention (control group)
Number of subjects: 150
Study: 16579697

Group type: EXPERIMENTAL
Intervention: Coronally positioned flap with enamel matrix derivative (EMD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Coronally positioned flap alone
Number of subjects: 22
Study: 12723458

Group type: EXPERIMENTAL
Intervention: Immediate-release formulation of Fampridine (10 mg) in patients with spinal cord injury (n = 11)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control subjects (n = 6) receiving oral doses of 10, 15, 20, and 25 mg of Fampridine
Number of subjects: 17
Study: 10677406

Group type: EXPERIMENTAL
Intervention: Treadmill exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dobutamine stress
Number of subjects: 10
Study: 9043560

Group type: EXPERIMENTAL
Intervention: Tetracaine 4% cream (30-minute application)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lidocaine-prilocaine cream (60-minute application)
Number of subjects: 66
Study: 7942580

Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 3218448

Group type: EXPERIMENTAL
Intervention: Short-term diazepam prophylaxis (n = 152)
Number of subjects: 289

Group type: COMPARATOR
Intervention: No prophylaxis (n = 137)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Young age at onset
Number of subjects: 289
Study: 29385840

Group type: EXPERIMENTAL
Intervention: Virtual Reality Assisted Intervention (VRAI) using Nintendo Wii Fit Plus
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional Rehabilitation Intervention (TRI) with theraband exercises
Number of subjects: 20
Study: 28495562

Group type: EXPERIMENTAL
Intervention: Protease inhibitor with no predicted-active NRTIs
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Protease inhibitor and raltegravir
Number of subjects: 1277

Group type: COMPARATOR
Intervention: Protease inhibitor monotherapy
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: One predicted-active NRTI
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Two or three active NRTIs
Number of subjects: 1277
Study: 24946155

Group type: EXPERIMENTAL
Intervention: Genetic counseling referral among average-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Genetic counseling referral among elevated-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Genetic counseling referral among high-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: BRCA testing among average-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: BRCA testing among elevated-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: BRCA testing among high-risk group
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Perceived ovarian cancer risk
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Discussion of family history with a doctor
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Belief that family history influenced risk
Number of subjects: 2524
Study: 23349733

Group type: EXPERIMENTAL
Intervention: L-carnitine (510 mg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 21944072

Group type: EXPERIMENTAL
Intervention: Single-legged hold exercise on a round foam roll (unstable surface)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Single-legged hold exercise on the floor (stable surface)
Number of subjects: 19
Study: 17615174

Group type: EXPERIMENTAL
Intervention: Semi-squat exercise (closed kinetic chain)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Straight leg raise exercise (open kinetic chain)
Number of subjects: 32
Study: 16199491

Group type: EXPERIMENTAL
Intervention: In-school mediated communication campaign combined with community-based media effort
Number of subjects: 4216

Group type: COMPARATOR
Intervention: Control communities (no intervention)
Number of subjects: 4216
Study: 12858328

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich meal test (CRMT)
Number of subjects: 7
Study: 14698699

Group type: EXPERIMENTAL
Intervention: Lamotrigine monotherapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional therapy (carbamazepine, phenytoin, or valproate)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 115
Study: 10674506

Group type: EXPERIMENTAL
Intervention: Mild hypothermic CPB (32 degrees C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normothermic CPB (>35 degrees C)
Number of subjects: 20
Study: 8888299

Group type: EXPERIMENTAL
Intervention: Background grating with a spatial frequency of about 4 cycles deg‐1 (experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Background grating with a duty cycle of 50% (experiment 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Size of the background grating (experiment 2)
Number of subjects: 0
Study: 1499145

Group type: EXPERIMENTAL
Intervention: Low workload exercise (50% VO2max, 60 min, 3 times a week for 10 weeks)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High workload exercise (75% VO2max, 60 min, 3 times a week for 10 weeks)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High workload exercise
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low workload exercise
Number of subjects: 26
Study: 6091505

Group type: EXPERIMENTAL
Intervention: Cytologic examination of induced sputum in addition to annual chest radiographic screening.
Number of subjects: 10387

Group type: COMPARATOR
Intervention: Annual chest radiographic screening (control group).
Number of subjects: 10387
Study: 3698521

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily + Nifedipine 30 mg daily
Number of subjects: 14
Study: 31489188

Group type: EXPERIMENTAL
Intervention: Lemna minor (20 g of protein)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Green peas (20 g of protein)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lemna minor and Green peas
Number of subjects: 12
Study: 27506727

Group type: EXPERIMENTAL
Intervention: PQ‐16‐containing deodorant (DEO1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available deodorant (DEO2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aluminium chlorohydrate-containing deodorant (DEO3)
Number of subjects: 0
Study: 24965759

Group type: EXPERIMENTAL
Intervention: Lidocaine test (LC) group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Glenohumeral (GH) group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups (LC and GH)
Number of subjects: 92
Study: 23669062

Group type: EXPERIMENTAL
Intervention: AM (Amlodipine) 10 mg/day + OM (Olmesartan Medoxomil) 40 mg/day
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: COMPARATOR
Intervention: AM (Amlodipine) 10 mg/day
Number of subjects: 157

Group type: COMPARATOR
Intervention: OM (Olmesartan Medoxomil) 40 mg/day
Number of subjects: 157
Study: 21515838

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 or 100 mg daily) in the diet-alone group
Number of subjects: 2539

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 or 100 mg daily) in the insulin group
Number of subjects: 2539

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 or 100 mg daily) in the OHA group
Number of subjects: 2539

Group type: COMPARATOR
Intervention: No aspirin in the insulin group
Number of subjects: 2539

Group type: COMPARATOR
Intervention: No aspirin in the OHA group
Number of subjects: 2539

Group type: COMPARATOR
Intervention: No aspirin in the diet-alone group
Number of subjects: 2539
Study: 19484213

Group type: EXPERIMENTAL
Intervention: Crisis Home Programme (CHP)
Number of subjects: 33
Study: 17038073

Group type: EXPERIMENTAL
Intervention: Collaborative care with access to a depression care manager and Problem Solving Treatment for 12 months
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 1801
Study: 15537736

Group type: EXPERIMENTAL
Intervention: Patients with hippocampal lesions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rats with hippocampal lesions
Number of subjects: 0
Study: 11558482

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 325

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 325

Group type: COMPARATOR
Intervention: Comparison of Atorvastatin vs Simvastatin
Number of subjects: 325
Study: 9070968

Group type: EXPERIMENTAL
Intervention: BMIPP
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thallium-201
Number of subjects: 28
Study: 8387973

Group type: EXPERIMENTAL
Intervention: Orlistat 50 mg three times a day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo three times a day
Number of subjects: 39
Study: 2892451

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cetirizine 5 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg
Number of subjects: 27
Study: 28472453

Group type: EXPERIMENTAL
Intervention: 4-Joule laser energy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 16-Joule laser energy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 26
Study: 28502038

Group type: EXPERIMENTAL
Intervention: Registered Intermediary interviews
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Verbal Labels interviews
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sketch Reinstatement of Context interviews
Number of subjects: 270

Group type: COMPARATOR
Intervention: Best-Practice police interview
Number of subjects: 270
Study: 25562115

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) program, 6-week, six-lesson
Number of subjects: 762

Group type: COMPARATOR
Intervention: Usual preventive mental health service for the first 6 months
Number of subjects: 762
Study: 23745303

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine hydrochloride 20 mL mixed with morphine 3 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 158
Study: 20873998

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) treatment
Number of subjects: 84

Group type: COMPARATOR
Intervention: Topical steroid treatment
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of RF and topical steroid treatment
Number of subjects: 84
Study: 18276928

Group type: EXPERIMENTAL
Intervention: Hyrax (tooth‐borne) palatal expander
Number of subjects: 39

Group type: COMPARATOR
Intervention: Acrylic‐bonded (tooth‐tissue borne) palatal expander
Number of subjects: 39
Study: 17063298

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrojejunostomy (LGJ)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Open gastrojejunostomy (OGJ)
Number of subjects: 24
Study: 14639566

Group type: COMPARATOR
Intervention: 150g added weight (placebo)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 770g added weight
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1625g added weight
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subject preference for 770g added weight
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subject preference for 150g added weight
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subject preference for 1625g added weight
Number of subjects: 10
Study: 10791374

Group type: EXPERIMENTAL
Intervention: Treatment guided by plasma N‐BNP concentration (BNP group)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standardised clinical assessment (clinical group)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: BNP group
Number of subjects: 69

Group type: COMPARATOR
Intervention: Clinical group
Number of subjects: 69
Study: 9290239

Group type: EXPERIMENTAL
Intervention: Hemiregional composite RR/LL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left facial composite (LL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Right facial composite (RR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hemiregional composite LL/RR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal orientation (RL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirror reversed (LR)
Number of subjects: 0
Study: 8369005

Group type: EXPERIMENTAL
Intervention: Sustained release diltiazem (180 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sustained release diltiazem (240 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sustained release diltiazem (300 mg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Sustained release diltiazem (360 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Immediate release diltiazem (60 mg, thrice a day)
Number of subjects: 5
Study: 3484423

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 58

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 58
Study: 31479032

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 3, 6.25, 12.5, or 25 mg weekly intramuscular injections
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29096836

Group type: EXPERIMENTAL
Intervention: Weekly lipoprotein apheresis by cascade plasma filtration (CPF) plus atorvastatin
Number of subjects: 356

Group type: COMPARATOR
Intervention: Atorvastatin alone
Number of subjects: 356
Study: 26112696

Group type: EXPERIMENTAL
Intervention: Granulocyte/Monocyte Adsorptive Apheresis (GMA)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Sham Apheresis
Number of subjects: 168
Study: 23805928

Group type: EXPERIMENTAL
Intervention: Resourcefulness training using expressive writing (RT-EW)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Resourcefulness training using verbal disclosure (RT-VD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of RT-EW and RT-VD
Number of subjects: 40
Study: 21444866

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy and surgery (CS group; n = 113)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Surgery alone (S group; n = 111)
Number of subjects: 224
Study: 18649004

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg (treatment group)
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 68
Study: 16935795

Group type: EXPERIMENTAL
Intervention: 3% diclofenac in 2.5% hyaluronic acid (Solaraze) with sunscreens
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 3% diclofenac in 2.5% hyaluronic acid (Solaraze) alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 32
Study: 15112937

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Craving
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biomarkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promising medications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiepileptic medications
Number of subjects: 0
Study: 11254068

Group type: EXPERIMENTAL
Intervention: Home-based multisystemic therapy (MST)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Hospitalization
Number of subjects: 113
Study: 9325830

Group type: EXPERIMENTAL
Intervention: Education and training package for leg ulcer management
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 264
Study: 8452573

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Closed-needle joint lavage
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Other intraarticular pathology
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery and Closed-needle joint lavage
Number of subjects: 32
Study: 3759475

Group type: EXPERIMENTAL
Intervention: Fee-for-service (FFS) plan with no cost sharing (free care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prepaid group practice (PGP)
Number of subjects: 0
Study: 29419362

Group type: EXPERIMENTAL
Intervention: Self-management program
Number of subjects: 40
Study: 26194867

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-olmesartan
Number of subjects: 40
Study: 25141100

Group type: EXPERIMENTAL
Intervention: 1‐, 3‐ or 6‐portion F&V/d for 8 weeks (FAVRIT study)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 2‐ or 5‐portion F&V/d for 16 weeks (ADIT study)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no F&V intake)
Number of subjects: 2
Study: 22479883

Group type: EXPERIMENTAL
Intervention: PCA morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: All other recruited patients
Number of subjects: 40
Study: 19730250

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation with helium (inspired oxygen fraction 0.35)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Noninvasive ventilation without helium
Number of subjects: 204
Study: 17394661

Group type: EXPERIMENTAL
Intervention: Routine exercise treadmill testing (ETT) at 6 weeks post-PCI
Number of subjects: 136
Study: 16350386

Group type: EXPERIMENTAL
Intervention: Low coronary perfusion pressure at 50 mmHg for 90 seconds followed by high at 80 mmHg for 90 seconds (group L‐H)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High coronary perfusion pressure at 80 mmHg for 90 seconds followed by low at 50 mmHg for 90 seconds (group H‐L)
Number of subjects: 12
Study: 12135589

Group type: EXPERIMENTAL
Intervention: Dexamethasone (24 mg/day) for 4 days and atracurium (0.3-0.6 mg/kg/h) for 2.8 days (group C)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dexamethasone (24 mg/day) for 4 days (group B)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: No treatment (group A)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (non-hemiplegic ICU patients)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 37
Study: 10534610

Group type: EXPERIMENTAL
Intervention: Four-session self-care intervention
Number of subjects: 0
Study: 7631051

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin and sulindac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Certain antihypertensive drugs (Ca2+ channel blockers, centrally acting alpha agonists, diuretics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thromboxane synthase inhibitors and selective inhibitors of PGH synthase-2
Number of subjects: 0
Study: 2067035

Group type: EXPERIMENTAL
Intervention: Bolus therapy with doxorubicin (60 mg/m2) and dacarbazine (750 mg/m2) intravenously on day 1
Number of subjects: 240

Group type: COMPARATOR
Intervention: Infusional therapy with doxorubicin (60 mg/m2) and dacarbazine (750 mg/m2) delivered by continuous intravenous infusion for 96 hours on days 1-4
Number of subjects: 240
Study: 6223483

Group type: EXPERIMENTAL
Intervention: Application of lidocaine to the tube
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (no lidocaine application)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Follow-up investigation
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Previous oral contraception use
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Questionnaire investigation
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Laparoscopic sterilization
Number of subjects: 189
Study: 30610657

Group type: EXPERIMENTAL
Intervention: Carfilzomib plus dexamethasone (Cd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib plus dexamethasone (Vd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Difference between Cd and Vd
Number of subjects: 0
Study: 30123243

Group type: EXPERIMENTAL
Intervention: Multidomain cognitive training (MCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 50
Study: 23768410

Group type: EXPERIMENTAL
Intervention: Intermittent urinary catheterisation
Number of subjects: 170
Study: 21079521

Group type: EXPERIMENTAL
Intervention: Bevacizumab in combination with paclitaxel and carboplatin (PCB)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel (PC)
Number of subjects: 850
Study: 20467615

Group type: EXPERIMENTAL
Intervention: 7‐mm‐long NanoTite External Hex implants (Biomet 3i)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10‐mm or longer implants placed in vertically augmented bone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vertical bone augmentation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 7‐mm short implants
Number of subjects: 60
Study: 17588704

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m2 over 30 min on Days 1 and 8 of a 21-day cycle (standard arm, N=33)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gemcitabine 1000 mg/m2 at a fixed dose rate of 10 mg/m2/min on Days 1 and 8 of a 21-day cycle (FDR arm, N=31)
Number of subjects: 64
Study: 15564706

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB) for 1 month
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB) for at least 6 months
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (anti-hypertensive drugs other than ARB)
Number of subjects: 65
Study: 11460004

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14